Patent Document ID: 7879569
Application ID: 11667406
Patent Flag: 1

Claim One:
1. A method of for diagnosing a subject with a myelodysplastic syndrome (MDS) in a subject, comprising analyzing predictive parameters in a blood sample of said subject; assigning a numerical value corresponding to a measure of each of said predictive parameters; comparing the said value to a value obtained for said predictive parameters from a control group; and assigning a numerical score reflecting the variance between the mean values obtained for said predictive parameters in said subject and that obtained for the same predictive parameters in said control group wherein said predictive parameters comprise: a measure of polymorphic neutrophil (PMN) granularity and expression of CD66, CD11a, CD10, and CD116 in cells of said blood sample, and wherein said numerical score provides indication of the presence or absence of said syndrome in said subject.